Puncture-Resistant Protected Inner Container Device
Executive Overview
This invention introduces a regulation-compliant, additive-free, protected glass blood collection system designed for high-value regenerative medicine applications, particularly Platelet-Rich Fibrin (PRF) and autologous blood therapies.
The device solves a major industry conflict:
- Glass tubes naturally activate clotting (ideal for PRF) but are unsafe and discouraged by OSHA/CDC.
- Plastic (PET) tubes are safer but require silica coatings or additives, which introduce contamination risk and regulatory limitations.
This patented system enables continued use of plain glass tubes while providing a puncture-resistant, impact-absorbing protective housing, creating a safer, superior clinical solution.
Investment Thesis
The invention enables:
- Reintroduction of biologically superior glass tubes
- Compliance with modern safety standards
- Differentiation in a crowded PRP/PRF marketplace
- Expansion into global regenerative medicine markets
With regulatory pressure increasing and regenerative procedures growing, this technology addresses both safety and biological performance simultaneously — a rare alignment.
PRF Tubes
The Problem
Modern regenerative treatments (PRF, PRP, autologous concentrates):
- Require clot activation
- Must avoid foreign additives
- Must comply with increasing safety regulations
- Involve repeated blood draws and centrifugation
Current options:
| Glass Tubes | Plastic Tubes |
|---|---|
| Natural clot activation | Require silica/additives |
| Additive-free | Chemical exposure risk |
| Risk of breakage | Lower clot quality |
| Increasing regulatory pressure | Widely adopted but biologically inferior for PRF |
The market lacks a safe, additive-free, glass-based solution.
The Solution
A triple-sealed, impact-resistant protective system that fully encloses a glass blood collection tube while preserving:
- Natural clot activation
- Vacuum integrity
- Puncture-site access
- Centrifuge compatibility
Technical Architecture
The system integrates four coordinated components:
1. Impact-Resistant Outer Protective Body
- Elongated housing
- Internal cavity sized for glass tube
- Made from impact-absorbing material (e.g., silicone, polymer)
- Optional stabilizing base (ring, suction cup, or silicone feet)
- Designed to fit standard centrifuges
2. Plain Glass Inner Tube
- Non-reactive glass
- Promotes natural coagulation
- Eliminates need for silica clot activators
- Compatible with PRF/PRP workflows
3. Dual-Structure Rubber Stopper
- Upper and lower portions separated by groove
- Centrally located puncture site
- Forms primary vacuum seal
4. Outer Closure Cap (Key Innovation)
- Frictionally engages stopper and tube
- Locks into protective housing
- Creates second and third seals
- Simultaneously extracts stopper when removed
Core Innovation: Triple-Seal Safety System
The device creates:
- Primary seal – stopper to glass tube
- Secondary seal – closure cap to stopper and tube
- Tertiary seal – closure cap to protective housing
This architecture provides:
- Enhanced contamination control
- Fragment containment if glass breaks
- Controlled stopper removal
- Reduced occupational injury risk
- Allows glass tube contact-free verification
- Contact-free PRF tube rim validation
Differentiating Advantages
1. Additive-Free PRF Capability
- No silica coatings
- No clot activators
- No anticoagulants
- Maintains autologous purity
2. Regulatory Alignment
- Addresses OSHA/CDC discouragement of exposed glass tubes
- Preserves safety without sacrificing biological performance
3. Centrifuge-Compatible Protection
- Designed for spinning while enclosed
- Reduces breakage risk during centrifugation
4. Non-Destructive Rim Inspection
- Transparent embodiments allow glass integrity validation
- Upper rim exposure feature enables inspection before use
5. Enhanced Clinical Safety
- Breakage mitigation
- Laceration risk reduction
- Containment of fragments
- Sample integrity preservation
Market Opportunity
Primary Target Segments
- Dental and oral surgery (PRF)
- Orthopedic regenerative medicine
- Aesthetic medicine
- Hair restoration
- Autologous biologic therapies
- Advanced wound care
Market Drivers
- Growing regenerative medicine market
- Increased demand for additive-free biologics
- Regulatory tightening on contamination
- Premium pricing tolerance in PRF markets
PRF procedures alone are expanding rapidly in dentistry and surgical settings, often requiring multiple tubes per session.
Competitive Positioning
| Feature | Standard Glass | PET Plastic | This Device |
|---|---|---|---|
| Natural clot activation | Yes | No | Yes |
| Additive-free | Yes | No | Yes |
| OSHA-compliant | No | Yes | Yes |
| Breakage protection | No | Yes | Yes |
| Fragment containment | No | Yes | Yes |
| PRF optimized | Yes | Limited | Yes |
This positions the device as a premium safety-enhanced glass system, rather than a commodity tube.
IP Strength
- Broad structural independent claim
- Protection of triple-seal architecture
- Stopper extraction mechanism
- Aligned puncture-site configuration
- Stabilizing base embodiments
- Transparent inspection embodiments
- Sterile packaging claims
The invention does not merely claim a sleeve — it claims an integrated mechanical system with coordinated sealing and extraction functionality.
Commercial Model
Potential monetization pathways:
- Premium disposable PRF kits
- Sterile multi-pack configurations
- White-label manufacturing for regenerative brands
- Licensing to dental supply companies
- OEM integration into centrifuge systems
Gross margins in regenerative consumables are typically high, especially for proprietary tube systems.
Strategic Value
This technology:
- Solves a regulatory-driven problem
- Enhances clinical safety
- Protects biological purity
- Targets a growing, premium medical segment
- Creates defensible IP around protected glass systems
It represents a category-creating solution:
“Protected Additive-Free Glass Regenerative Collection System.”
Investment Thesis
The invention enables:
- Reintroduction of biologically superior glass tubes
- Compliance with modern safety standards
- Differentiation in a crowded PRP/PRF marketplace
- Expansion into global regenerative medicine markets
With regulatory pressure increasing and regenerative procedures growing, this technology addresses both safety and biological performance simultaneously — a rare alignment.
Patented Biomedical device
PRF-BRGF System
